Updating results

16 results for template

Sort: Relevance | Date

User guide for the cost comparison company evidence submission template (PMG32)

User guide for the cost comparison company evidence submission template

Published April 2017 Last updated April 2017

Single technology appraisal: User guide for company evidence submission template (PMG24)

Single technology appraisal: User guide for company evidence submission template

Published January 2015 Last updated April 2017 Last updated April 2017

Midcarpal hemiarthroplasty for wrist arthritis (IPG663)

Evidence-based recommendations on midcarpal hemiarthroplasty (using a metal implant to create an artificial wrist joint) for wrist arthritis in adults

Interventional procedures guidance Published October 2019

Aortic valve reconstruction with processed bovine pericardium (IPG604)

Evidence-based recommendations on aortic valve reconstruction with processed bovine pericardium (using new valve made from chemically treated cow pericardium)

Interventional procedures guidance Published February 2018

Prostate cancer: diagnosis and management (NG131)

This guideline covers the diagnosis and management of prostate cancer in secondary care, including information on the best way to diagnose and identify different stages of the disease, and how to manage adverse effects of treatment. It also includes recommendations on follow-up in primary care for people diagnosed with prostate cancer.

NICE guideline Published May 2019

Patient group directions (MPG2)

This guideline covers good practice for developing, authorising, using and updating patient group directions. It also offers advice on deciding whether a patient group direction is needed.

Medicines practice guideline Published August 2013 Last updated March 2017

Tuberculosis (NG33)

This guideline covers preventing, identifying and managing latent and active tuberculosis (TB) in children, young people and adults. It aims to improve ways of finding people who have TB in the community and recommends that everyone under 65 with latent TB should be treated. It describes how TB services should be organised, including the role of the TB control board.

NICE guideline Published January 2016 Last updated September 2019

Biosimilar medicines (KTT15)

The key therapeutic topic biosimilar medicines has been retired from the 2019 update of medicines optimisation: key therapeutic topics. The version published in 2018 is available here for information but it has not been updated since February 2018. Like all the other key therapeutic topics it is not formal NICE guidance.

Key therapeutic topic Published February 2016 Last updated February 2018

Guide to the processes of technology appraisal (PMG19)

Guide to the processes of technology appraisal

Published September 2014 Last updated May 2018 Last updated May 2018

Medicines optimisation in chronic pain (KTT21)

This document summarises the evidence base on medicines optimisation in chronic pain. It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance.

Key therapeutic topic Published January 2017 Last updated September 2019

Evidence summaries: new medicines – Integrated process statement (PMG11)

Evidence summaries: new medicines – Integrated process statement

Published May 2013 Last updated March 2017 Last updated March 2017

Evidence summaries: unlicensed and off-label medicines – Integrated process statement (PMG14)

Evidence summaries: unlicensed and off-label medicines – Integrated process statement

Published May 2013 Last updated March 2017 Last updated March 2017